Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report)’s stock price passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $7.87 and traded as low as $7.71. Alpha Teknova shares last traded at $7.77, with a volume of 420,861 shares changing hands.
Analyst Ratings Changes
A number of equities analysts have issued reports on TKNO shares. TD Cowen raised their target price on Alpha Teknova from $7.00 to $11.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. BTIG Research raised Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price target for the company in a research note on Tuesday, August 11th. Wall Street Zen upgraded shares of Alpha Teknova from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Zacks Research raised shares of Alpha Teknova to a “hold” rating in a research note on Thursday, August 6th. Finally, Roth Capital began coverage on shares of Alpha Teknova in a report on Wednesday, August 5th. They set a “buy” rating and a $7.00 price objective for the company. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Alpha Teknova presently has an average rating of “Moderate Buy” and an average target price of $8.75.
Read Our Latest Analysis on Alpha Teknova
Alpha Teknova Trading Down 5.4%
The business has a 50 day moving average of $7.87 and a 200-day moving average of $5.14. The company has a current ratio of 3.56, a quick ratio of 3.48 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $488.73 million, a P/E ratio of -26.79 and a beta of 0.96.
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. Alpha Teknova had a negative net margin of 34.76% and a negative return on equity of 24.95%. The firm had revenue of $12.70 million for the quarter, compared to the consensus estimate of $11.71 million. Analysts anticipate that Alpha Teknova, Inc. will post -0.27 EPS for the current fiscal year.
Institutional Investors Weigh In On Alpha Teknova
A number of hedge funds and other institutional investors have recently made changes to their positions in TKNO. Deutsche Bank AG bought a new stake in Alpha Teknova in the 2nd quarter valued at $62,000. Ieq Capital LLC acquired a new position in Alpha Teknova in the 2nd quarter worth $62,000. Susquehanna International Group LLP bought a new position in Alpha Teknova during the 2nd quarter worth about $115,000. Fielder Capital Group LLC bought a new position in Alpha Teknova during the 2nd quarter worth about $143,000. Finally, Marshall Wace LLP bought a new position in Alpha Teknova during the 3rd quarter worth about $330,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.
About Alpha Teknova
Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.
Featured Stories
- Five stocks we like better than Alpha Teknova
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
